Search

Spain needs a clear regulatory framework and support for the biotechnological industry with long-term investments, support that specifically addresses the needs of biotech companies, and measures to

The ENVI Committee of the European Parliament advocates expanding the category 1 of NGTs, allowing their use in organic agriculture, and reducing labeling and traceability obligations.

Lead candidate KYN-5356, a first-in-class small Molecule KAT-II inhibitor advancing toward the clinic for cognitive impairment associated with schizophrenia.

Multiple primary endpoints include reduction in agitation and aggression and overall BPD disease improvement.

Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13 at at Old Billingsgate in London (UK). Click on link for more info about the LSX Investival Showcase

On the occasion of World One Health Day, we spoke with Rosario Cerrato, Director of Innovation at Ingulados, a technology-based company that researches to improve 'health' by seeking solutions in

BCN HEALTH conducted a retrospective study based on the records of patients hospitalized due to endometriosis and treated in Spanish public and private hospitals between January of 2009 and December

Spain positions itself as one of the leading countries in the field of advanced therapies, both in terms of scientific expertise and the number of clinical trials.

Nanodecal's funding round aims to raise €600,000 to support the development of a rapid test for detecting respiratory superbugs in chronic respiratory patients.

Research and development (R&D) expenses of $3.8 and $12.2 million for the quarter and nine months ended September 30, 2023, respectively

Spain's first Agri-Food Tech-focused Venture Capital fund kicks off with an initial capital of over 40 million, with a maximum target of 80 million, to invest in technological innovation as a solution

VIVEbiotech has received the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de la Empresa Vasca/Basque Business Night for its management model to boost the new

Meet NANODECAL, our new partner. We talked to its CEO, Roberto de la Rica.

The new center- which will be fully operational in mid-2024 – will have a surface area of ​​1,200 m2 and will be equipped with the most cutting-edge technology.